Page last updated: 2024-10-26

eperisone and Diabetes Mellitus, Type 2

eperisone has been researched along with Diabetes Mellitus, Type 2 in 1 studies

eperisone : A racemate that is an equimolar mixture of (R)- and (S)-eperisone. It is used (as the hydrochloride salt) as a muscle relaxant for the symptomatic treatment of muscle spasm and spasticity.
1-(4-ethylphenyl)-2-methyl-3-(piperidin-1-yl)propan-1-one : An aromatic ketone that is N-propylpiperidine in which a hydrogen at positon 2 of the propyl group is replaced by a p-ethylbenzoyl group.

Diabetes Mellitus, Type 2: A subclass of DIABETES MELLITUS that is not INSULIN-responsive or dependent (NIDDM). It is characterized initially by INSULIN RESISTANCE and HYPERINSULINEMIA; and eventually by GLUCOSE INTOLERANCE; HYPERGLYCEMIA; and overt diabetes. Type II diabetes mellitus is no longer considered a disease exclusively found in adults. Patients seldom develop KETOSIS but often exhibit OBESITY.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Sakakida, K1
Wei, FY1
Senokuchi, T1
Shimoda, S1
Kakuma, T1
Araki, E1
Tomizawa, K1

Trials

1 trial available for eperisone and Diabetes Mellitus, Type 2

ArticleYear
Study Design of a Phase II Clinical Trial to Assess the Efficacy and Safety of Eperisone in Japanese Type 2 Diabetes Patients with Risk and Non-risk Alleles of CDKAL1.
    Acta medica Okayama, 2018, Volume: 72, Issue:4

    Topics: Adult; Aged; Alleles; Diabetes Mellitus, Type 2; Glycated Hemoglobin; Humans; Middle Aged; Parasympa

2018